These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 21318770)

  • 1. Animal models of induced apoptotic death in the substantia nigra.
    Oo TF; Burke RE
    Methods Mol Med; 2001; 62():89-99. PubMed ID: 21318770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis and Parkinson's disease.
    Lev N; Melamed E; Offen D
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):245-50. PubMed ID: 12657363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats.
    Wang YQ; Bian GL; Bai Y; Cao R; Chen LW
    Neurochem Int; 2008 Sep; 53(3-4):56-62. PubMed ID: 18639597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct nuclear and cytoplasmic localization of caspase cleavage products in two models of induced apoptotic death in dopamine neurons of the substantia nigra.
    Oo TF; Siman R; Burke RE
    Exp Neurol; 2002 May; 175(1):1-9. PubMed ID: 12009755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of alpha-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson's disease rat model.
    Hayashita-Kinoh H; Yamada M; Yokota T; Mizuno Y; Mochizuki H
    Biochem Biophys Res Commun; 2006 Mar; 341(4):1088-95. PubMed ID: 16460685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis in the mammalian CNS: Lessons from animal models.
    Lossi L; Cantile C; Tamagno I; Merighi A
    Vet J; 2005 Jul; 170(1):52-66. PubMed ID: 15993789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of prostate apoptosis response-4 protein in substantia nigra of Parkinson's disease autopsies.
    Moos T; Jensen PH
    Acta Neuropathol; 2004 Jan; 107(1):23-6. PubMed ID: 13680279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician Education: Apoptosis.
    Kataoka S; Tsuruo T
    Oncologist; 1996; 1(6):399-401. PubMed ID: 10388021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of prostate apoptosis response-4 in degeneration of dopaminergic neurons in models of Parkinson's disease.
    Duan W; Zhang Z; Gash DM; Mattson MP
    Ann Neurol; 1999 Oct; 46(4):587-97. PubMed ID: 10514095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging.
    Anglade P; Vyas S; Hirsch EC; Agid Y
    Histol Histopathol; 1997 Jul; 12(3):603-10. PubMed ID: 9225140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tetracycline-regulated adenovirus encoding dominant-negative caspase-9 is regulated in rat brain and protects against neurotoxin-induced cell death in vitro, but not in vivo.
    Ebert AD; Chen F; He X; Cryns VL; Bohn MC
    Exp Neurol; 2005 Feb; 191 Suppl 1():S80-94. PubMed ID: 15629764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
    Anglade P; Vyas S; Javoy-Agid F; Herrero MT; Michel PP; Marquez J; Mouatt-Prigent A; Ruberg M; Hirsch EC; Agid Y
    Histol Histopathol; 1997 Jan; 12(1):25-31. PubMed ID: 9046040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.
    Banati RB; Daniel SE; Blunt SB
    Mov Disord; 1998 Mar; 13(2):221-7. PubMed ID: 9539333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons.
    Albéri L; Sgadò P; Simon HH
    Development; 2004 Jul; 131(13):3229-36. PubMed ID: 15175251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
    Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ
    Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte macrophage-colony stimulating factor protects against substantia nigra dopaminergic cell loss in an environmental toxin model of Parkinson's disease.
    Mangano EN; Peters S; Litteljohn D; So R; Bethune C; Bobyn J; Clarke M; Hayley S
    Neurobiol Dis; 2011 Jul; 43(1):99-112. PubMed ID: 21377529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.